(ZYME) – Hot Corp. News
-
Jazz (JAZZ) and Zymeworks (ZYME) Enter License Agreement to Develop and Commercialize Zanidatamab
-
Zymeworks (ZYME) Says Clinical Data for its Novel Bispecific Antibody, ZW25, Presented at ASCO
-
-
-
Back to ZYME Stock Lookup